Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 79,437 | 85,735 | 86,327 | 88,565 | 93,247 |
| Cost of Goods | 1,268 | 1,254 | 1,216 | 1,234 | 1,878 |
| Gross Profit | 78,169 | 84,481 | 85,111 | 87,331 | 91,369 |
| Operating Expenses | 58,799 | 54,225 | 60,608 | 52,303 | 54,536 |
| Operating Income | 19,638 | 30,510 | 24,719 | 35,262 | 37,711 |
| Other Income | 275 | 297 | 622 | 1,010 | 1,471 |
| Pre-tax Income | 19,913 | 30,807 | 25,341 | 36,272 | 39,182 |
| Income Tax | -3,552 | 4,813 | 3,716 | 7,945 | 9,117 |
| Net Income Continuous | 23,465 | 25,994 | 21,625 | 28,327 | 30,065 |
| Net Income | $23,465 | $25,994 | $21,625 | $28,327 | $30,065 |
| EPS Basic Total Ops | 0.20 | 0.22 | 0.19 | 0.25 | 0.26 |
| EPS Basic Continuous Ops | 0.20 | 0.22 | 0.19 | 0.25 | 0.26 |
| EPS Diluted Total Ops | 0.18 | 0.20 | 0.17 | 0.23 | 0.25 |
| EPS Diluted Continuous Ops | 0.18 | 0.20 | 0.17 | 0.23 | 0.25 |
| EBITDA(a) | $21,575 | $31,072 | $25,283 | $35,771 | $38,313 |